Financial Times · 2026-11-11 04:32 UTC

The biotech group most famous for its Covid-19 jab believes its personalised cancer vaccine, which is expected to win US regulatory approval next year, could be bigger than the bestselling oncology drug ever

Loading the story on Tree News…